Bringing a new medical treatment to market is a challenging process - one that is not always fruitful. It is estimated that clinical development programs fail four times out of five. Although a clinical trial can fail for many reasons, poor trial design is often the main cause for failure.
Particularly for first-in-human (FIH) trials, poor study planning can result in project cancellation, study redesign or product specification changes, all of which lead to soaring costs. A well-planned trial design helps mitigate failure risk and set the trial on a path to success.
Download this white paper and discover the most important steps in successfully designing your clinical trial.